Advertisement
YOU ARE HERE: LAT HomeCollectionsInjections
IN THE NEWS

Injections

NEWS
October 11, 2012 | By Monte Morin
Roughly 14,000 patients in 23 states have been injected with a tainted pain-killing medication that is suspected of causing a nationwide outbreak of rare fungal meningitis, according to the Centers for Disease Control . At a news conference Thursday, CDC officials said they had located and notified 90% of those individuals -- just over 12,000. They also warned that in some cases, onset of fungal infection was taking much longer than typically observed, and that exposed patients needed to remain vigilant for signs of illness over the next several months.  "We know we are not out of the woods yet," said said Dr. Todd Weber, an incident manager for the CDC. "We are making sure patients understand that should they develop symptoms of meningitis or a joint infection in the coming weeks, they need to seek medical care immediately.
Advertisement
NATIONAL
October 11, 2012 | By Michael Muskal
The death toll from an outbreak of a rare form of fungal meningitis has risen to 14, the federal Centers for Disease Control and Prevention said Thursday. Further, the first Western state has reported a case. In a posting on its website, the CDC said 170 cases -- including 14 deaths -- have now been reported across the  country. The agency said 11 states now have cases and that Idaho, the first Western state, has been added to the list. Other states that have reported cases are Florida, Indiana, Maryland, Michigan, Minnesota, New Jersey, North Carolina, Ohio, Tennessee and Virginia.
NATIONAL
October 9, 2012 | By Laura J. Nelson, Los Angeles Times
Shatarka Nuby just wanted to be pretty. She longed to fill out her jeans, to look curvier in her bikini, so she sought out a man with a syringe who said he could sell her the body she wanted for $1,000. In her bedroom in South Florida, witnesses later told police, Nuby handed Oneal Ron Morris a wad of cash and stretched out on her stomach. Morris plunged a syringe filled with clear liquid into Nuby's hips and buttocks, the onlookers said. Her skin began to rise under the needle.
SPORTS
September 10, 2012 | By Dylan Hernandez, Los Angeles Times
SAN FRANCISCO - A day after receiving a couple of injections in his left shoulder, Matt Kemp remained hopeful he could return to the Dodgers' lineup Tuesday for their series opener in Arizona. The Dodgers have a day off Monday. Kemp didn't take batting practice before the Dodgers' 4-0 loss to the San Francisco Giants on Sunday, but he played catch. "I pray to God I'll be back," he said. Kemp underwent a contrast MRI exam the previous day that required dye to be injected in his shoulder.
SPORTS
September 9, 2012 | By Steve Dilbeck
Bad news, now downright scary news, seems to be coming at the Dodgers in waves. In what would have been his biggest outing of the season, Clayton Kershaw was scratched from his scheduled start against the Giants on Sunday afternoon with a sore hip. Kershaw referred reporters to Manager Don Mattingly, who is scheduled to meet with reporters later in the afternoon. The Dodgers just sent a message on Twitter through dodgers.com that Kershaw received a cortisone injection for a sore hip and he could be ready to start Tuesday.
SPORTS
August 30, 2012 | By Gary Klein
Former USC football player Armond Armstead filed a lawsuit against the school and other defendants Thursday, claiming he received improperly administered painkilling injections that caused him to suffer a heart attack and hurt his chances for an NFL career. The University Park Health Center and James Tibone, the Trojans' team physician, and an unnamed pharmaceutical company also are named as defendants in a 38-page lawsuit that was filed in Los Angeles Superior Court. The suit also claims that USC representatives concealed the injections from other physicians and also hindered Armstead's attempt to transfer to another school for his senior season and to be drafted by an NFL team.
SCIENCE
August 1, 2012 | By Thomas H. Maugh II, Los Angeles Times
Rabies is generally thought to be universally fatal, but new evidence suggests that is not always the case. A study in Peru suggests that some people -- admittedly a very small percentage of the population -- may have a natural resistance to the rabies virus that protects them from serious illness when they become infected. The results suggest that it may be possible to develop new ways to prevent and treat rabies. Most Americans associate rabies with dogs, but the virus is most commonly carried by bats.  Experts estimate that rabies kills at least 55,000 people each year in Africa and Asia alone, and the disease appears to be on the rise in China, the former Soviet republics, and Central and South America.
ENTERTAINMENT
July 30, 2012 | By David Pagel
At Cherry and Martin, a three-artist show takes visitors back to school. But rather than educating us about anything, “Bush of Ghosts” treats the pranks students play as an art form. No one does this better than Nathan Mabry, whose life-size bronze sculpture of a cowboy astride a bucking bronco would be right at home in any collection of Western art, except that the cowboy's head has been replaced by that of a ferocious monster, its fang-filled mouth open wide. Nearly 12 feet tall, Mabry's statue makes Frederic Remington look as hip - and significantly more ambitious - than many young sculptors, who seem to want nothing more than for their work to be accepted as "unmonumental.
IMAGE
July 22, 2012 | Janet Kinosian
Images of hippie-era love beads and Native American-inspired headbands can condemn beading in jewelry and accessories to appearing quaint at best. But the artisan level of contemporary beaders crafting today's fashion jewelry and accessories puts that image to rest. Their work has a decidedly modern, vibrant twist that makes it uniquely their own. For starters, the beads themselves are often a global affair. A bracelet might sport rare German vintage glass beads from the 1920s and '30s, antique African trading or vintage Japanese metal beads.
NATIONAL
July 18, 2012 | By Molly Hennessy-Fiske
HOUSTON -- Texas officials Wednesday were preparing for the state's first single-drug lethal injection after the U.S. Supreme Court  rejected the appeals of death row inmate Yokamon Hearn. The justices refused Hearn's appeals hours before he was scheduled to be executed for the 1998 murder of Frank Meziere, a stockbroker shot after a carjacking at a Dallas car wash. Hearn's execution, which could start any time after 6 p.m. Central time, will be the sixth in Texas this year -- for a total of  482 since the state began executing inmates by lethal injection in December 1982, a Texas Department of Criminal Justice spokesman told the Los Angeles Times.
Los Angeles Times Articles
|